Frugal Billionaire Warren Buffett Drives A 2014 Car And Looks For Hail-Damaged Deals... BIG DEAL: STONEDINVESTOR DRIVES AN 87 JEEP WAGONEER>
OMG DELTA-!! Huge numbers! Delta Air Lines sees FY23 revenue up 17%-20%, consensus $53.54B » 07:10 DAL
Aemetis, Inc. Seven dairy digesters, 40-mile biogas pipeline, centralized Biogas-to-RNG facility, and utility pipeline interconnection are operating 24x7 to deliver RNG for the displacement of petroleum-based fuels in trucks, buses, and cars CUPERTINO, CA, June 27, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Aemetis, Inc. (NASDAQ: AMTX), a renewable natural gas (RNG) and renewable fuels company focused on negative carbon intensity products, announced today that its Aemetis Biogas subsidiary is operating the Central Dairy Project production facilities 24 hours per day, seven days per week, and exceeded the RNG production plan by approximately 20% during Q2 2023. “Production rates at our dairy digesters are notably higher than our original projections,” stated Andy Foster, President of Aemetis Biogas. “Our biogas pipeline, biogas-to-RNG production facility and utility gas pipeline interconnection are running smoothly, converting dairy biogas into valuable RNG delivered into the PG&E natural gas pipeline system.” “The June 21st announcement by the federal EPA of the Renewable Volume Obligation for years 2023, 2024 and 2025 significantly increased the mandate for the D3 Renewable Identification Numbers (RINs) generated by RNG,” said Eric McAfee, Chairman and CEO of Aemetis, Inc. “Each MMBtu of dairy RNG generates 11.7 D3 RINs and the Aemetis Five Year Plan expects 1 million MMBtu in year 2025. The price of D3 RINs has already increased about 30% to $2.85 since the RVO was announced last week.”
IQV is always an interesting chart. It was in a fabulous uptrend till about 5 days ago. It broke but today gets a saving upgrade. So I'm a bit suspicious of that... Lets track-- IQV Profitability Profit Margin 7.28% Operating Margin (ttm) 12.74% Management Effectiveness Return on Assets (ttm) 4.55% Return on Equity (ttm) 17.80% Income Statement Revenue (ttm) 14.49B
ENVX Enovix Corporation $13.12-0.67 (-4.86%)4:00 PM 06/26/23 NASDAQ | $USD | Pre-Market: $14.00 +0.88 (+6.71%) <-- US Army order-?8:46 AM
I dunno this seems a little wishy washy- Enovix Corporation Batteries Include the Company’s Unparalleled Safety System—BrakeFlow™ Enovix Battery Enovix cell design enables a battery with high energy density and capacity without compromising safety. FREMONT, Calif., June 27, 2023 (GLOBE NEWSWIRE) -- Enovix Corporation (“Enovix”) (Nasdaq: ENVX), an advanced silicon battery company, today announced the progression of its U.S. Army program, with a commitment to producing commercial cells for use within U.S. Army soldier’s central power source, called the Conformal Wearable Battery (CWB). This agreement progresses this program to the next critical step towards full volume production. Created by Inventus Power, the CWB powers vital communications equipment and other devices. “Our cells provide a significant energy density advantage compared to other cells on the market today, and I’m proud that our team has successfully designed and produced BrakeFlow™-enabled custom cells for Inventus Power and the U.S. Army,” said Dr. Raj Talluri, President & CEO of Enovix. “This achievement is yet another proof point on our journey to scale.” Enovix cells will be used to build pre-production CWB packs. Today, U.S. soldiers carry more than 60 pounds of gear, including batteries, to power critical equipment. The Enovix cell has the potential to nearly double the energy density of the current CWB cells, which could result in substantial operational advantages including longer lasting and lighter battery packs. Another key advantage for the Army is Enovix BrakeFlow™ technology, a breakthrough safety system that provides an extra layer of protection inside the cell. If an internal short does occur, with BrakeFlow incorporated, instead of a sudden catastrophic release of energy the battery is designed to discharge slowly and safely.
Why You Should Retain IQVIA Holdings (IQV) Stock for Now IQVIA Holdings Inc.’s IQV shares have gained 8.3% in the past month, outperforming the 3.8% rise of the Zacks S&P 500 composite. IQV has an impressive Growth Score of B. This style score condenses all the essential metrics from the company’s financial statements to get a true sense of the quality and sustainability of its growth. It has a long-term (three to five years) expected EPS growth rate of 10.7%. IQVIA Holdings Inc. Price IQVIA Holdings Inc. Price IQVIA Holdings Inc. price | IQVIA Holdings Inc. Quote Factors That Bode Well IQVIA’s enormous treasure trove of information is a distinguishing asset and also perhaps a big barrier to entry for competitors. It has a huge collection of healthcare information that encompasses more than one billion comprehensive, longitudinal, non-identified patient records across sales, prescription and promotional data, electronic medical records, medical claims, genomics, and social media. The company’s burgeoning information set contains around 60 petabytes of proprietary data sourced from around 150,000 data suppliers and covers more than one million data feeds globally. It delivers information and insights on roughly 85% of the world’s pharmaceuticals. IQVIA’s unique ability to standardize, organize and integrate this information through applying sophisticated analytics and global technology infrastructure helps it to build a strong client base. In 2022, the company added 275 more customers to its tally. IQVIA has a consistent record of share repurchases. In 2022, 2021 and 2020, the company repurchased shares worth $1.17 billion, $406 million and $447 million, respectively. Such moves not only instill investors’ confidence but also positively impact earnings per share.